GDP
AZN icon

Great Diamond Partners’s AstraZeneca AZN Stock Holding History

Great Diamond Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Sell
1,784
-165
-8% -$31K 0.06% 202
2026
Q1 		$384K Sell
1,949
-182
-9% -$35.1K 0.07% 183
2025
Q4 		$392K Sell
2,131
-13
-0.6% -$2.28K 0.08% 173
2025
Q3 		$329K Sell
2,144
-141
-6% -$21.3K 0.06% 183
2025
Q2 		$319K Buy
2,285
+123
+6% +$17.2K 0.07% 177
2025
Q1 		$318K Sell
2,162
-98
-4% -$14.2K 0.09% 137
2024
Q4 		$296K Sell
2,260
-176
-7% -$24.6K 0.08% 145
2024
Q3 		$380K Sell
2,436
-745
-23% -$120K 0.1% 130
2024
Q2 		$496K Sell
3,181
-230
-7% -$34.6K 0.12% 128
2024
Q1 		$462K Sell
3,411
-100
-3% -$13.2K 0.11% 137
2023
Q4 		$473K Sell
3,511
-330
-9% -$42.9K 0.12% 136
2023
Q3 		$520K Sell
3,841
-305
-7% -$41.7K 0.14% 126
2023
Q2 		$593K Sell
4,146
-53
-1% -$7.8K 0.16% 120
2023
Q1 		$583K Buy
4,199
+33
+0.8% +$4.44K 0.17% 117
2022
Q4 		$565K Sell
4,166
-11
-0.3% -$1.38K 0.17% 109
2022
Q3 		$458K Buy
4,177
+55
+1% +$6.98K 0.16% 126
2022
Q2 		$544K Buy
4,122
+942
+30% +$124K 0.18% 108
2022
Q1 		$421K Buy
3,180
+517
+19% +$62K 0.12% 139
2021
Q4 		$310K Buy
2,663
+243
+10% +$28.6K 0.08% 175
2021
Q3 		$290K Buy
2,420
+53
+2% +$6.17K 0.08% 169
2021
Q2 		$283K Buy
2,367
+142
+6% +$15.6K 0.08% 164
2021
Q1 		$221K Buy
2,225
+100
+5% +$10.1K 0.07% 185
2020
Q4 		$212K Sell
2,125
-767
-27% -$81.2K 0.07% 173
2020
Q3 		$316K Sell
2,892
-176
-6% -$19.6K 0.12% 118
2020
Q2 		$324K Sell
3,068
-77
-2% -$7.95K 0.13% 109
2020
Q1 		$280K Buy
3,145
+1,939
+161% +$183K 0.14% 97
2019
Q4 		$120K Buy
+1,206
New +$114K 0.05% 200

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Great Diamond Partners's AZN Position: Q2 2026 in Review

Great Diamond Partners reduced its AstraZeneca (AZN) stake by 8.5% in Q2 2026, selling an estimated $31K and leaving 1,784 shares worth $338K. The position accounts for 0.06% of the portfolio, ranked #202.

Great Diamond Partners first reported a position in AZN in Q4 2019 and has held it in 27 quarters since. The position peaked at $593K in Q2 2023. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Great Diamond Partners held 1,784 shares of AstraZeneca worth $338K as of Q2 2026.
  • Great Diamond Partners sold 165 AstraZeneca shares in Q2 2026, an estimated $31K.
  • AstraZeneca made up 0.06% of Great Diamond Partners's portfolio in Q2 2026, its #202 holding.
  • Great Diamond Partners first reported a position in AstraZeneca in Q4 2019 and has held it in 27 quarters since.
  • Great Diamond Partners's AstraZeneca position peaked at $593K in Q2 2023.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Great Diamond Partners's 13F filing for Q2 2026, filed 17 Jul 2026.